Target intelligence / Profile preview

Taste receptor type 2 member 20 (TAS2R20)

Target
TAS2R20
Molecular classification
G protein-coupled receptor (GPCR), Receptor, Bitter taste receptor, Class A (Rhodopsin-like) GPCR family
01

Overview

Taste receptor type 2 member 20 (TAS2R20) is a member of the bitter taste receptor family, which belongs to the G protein-coupled receptor (GPCR) superfamily. TAS2Rs, including TAS2R20, mediate the detection of diverse bitter compounds in the oral cavity and provide an evolutionary advantage by warning the organism against ingestion of potentially harmful substances, as many toxins taste bitter. The TAS2R gene family comprises around 25 genes in humans; each receptor exhibits a unique but sometimes overlapping spectrum of ligand sensitivity. They function via a single orthosteric binding pocket, which can accommodate structurally diverse bitter agonists. TAS2R20 is expressed in taste-bud cells of the tongue and, like other taste receptors, signals through G proteins, particularly gustducin, to trigger neuronal responses that result in bitter taste perception. Although highly variable at the genetic and functional levels, there is no currently confirmed direct disease role or approved therapeutic targeting for TAS2R20 itself[1][2].

Other names
TAS2R20T2R20TAS2R49T2R49TAS2R56T2R56Taste receptor type 2 member 49Taste receptor type 2 member 56Taste receptor, type 2, member 49Taste receptor, type 2, member 56
02

Mechanism of action

For agonists: Activation of TAS2R20 by bitter compounds leads to G protein-mediated intracellular signaling (involving gustducin and subsequent signal cascades), resulting in perception of bitter taste[1][2]. No antagonists or other drug-based mechanisms of action are reported in current literature for TAS2R20.

03

Biological functions

Detection of bitter flavorsSignal transductionChemical sensing in gustatory systemProtection against ingestion of toxic substances (many bitter compounds are natural toxins)
04

Disease associations

Other (No direct, established roles in major human diseases, though taste receptor gene variation may influence dietary habits and disease risk indirectly)
05

Safety considerations

None reported. TAS2R20 is not currently a direct drug target; modulation of taste receptors in drug development generally poses challenges related to selectivity and unintended taste disturbances (dysgeusia), not organ toxicity
06

Interacting drugs

No conventional approved drugs directly target TAS2R20 for therapeutic use. Bitter compounds (agonists) activate the receptor, and large-scale screening has identified various natural and synthetic substances as potential agonists for different TAS2Rs, but specific agonists for TAS2R20 are not well established in the literature

1 more in the full profile.

07

Biomarkers

There are no validated biomarkers for TAS2R20 relevant to patient selection or therapeutic monitoring

Beyond the preview

Go deeper on Taste receptor type 2 member 20 (TAS2R20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taste receptor type 2 member 20 (TAS2R20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call